Welcome
Support Centre
30 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Transfusion Requirements in Paediatric Intensive Care Unit
ISRCTN ISRCTN37246456
DOI 10.1186/ISRCTN37246456
ClinicalTrials.gov identifier
EudraCT number
Public title Transfusion Requirements in Paediatric Intensive Care Unit
Scientific title Transfusion Requirements in Paediatric Intensive Care Unit: a multicentre randomised controlled non-inferiority clinical trial
Acronym TRIPICU
Serial number at source CIHR-RCT 130770
Study hypothesis A restrictive transfusion strategy, using pre-storage leukocyte reduced packed red blood cell units, would not be inferior to a liberal strategy in its effects on multiple organ dysfunction.
Lay summary Not provided at time of registration
Ethics approval IRB approval was gained from the Comité d'éthique à la recherche for all participating sites prior to participant recruitment.
Study design Multicentre randomised controlled non-inferiority trial
Countries of recruitment Belgium, Canada, United Kingdom, United States of America
Disease/condition/study domain Anaemia
Participants - inclusion criteria 1. Stable critically ill children with haemoglobin concentrations below 9.5/dL g within seven days of admission to intensive care unit
2. Aged greater than or equal to 3 days or less than or equal to 14 years old, either sex
Participants - exclusion criteria 1. Post-conception age less than 40 weeks at the time of randomisation
2. Present age less than three days after birth (at term) or less than 14 years old
3. Weight less than 3 kg at the time of randomisation
4. Previous enrolment of a patient in this trial
5. Never discharged home following admission to a neonatalogy intensive care unit
6. Pregnant
7. Post-operative care of a neonatal cardiac surgery who is less than 28 days of age when the surgery occurs
8. Post-operative care of a planned surgery for a cyanotic cardiopathy, unless the cardiopathy was corrected and the patients is older than 28 days of age
9. The patient has an uncorrected cyanotic cardiopathy
10. Haemolytic anaemia (example: sickle cell disease, haemolytic uraemic syndrome)
11. Inability to receive blood for transfusion (e.g. presence of multiple antibodies, Jehovah Witness or other cultural/religious ideology)
12. Hypoxaemia (saturation of oxyhaemoglobin [SpO2] less than or equal to 90% measured using pulse oxymeter) that persists despite a fraction of inspired oxygen (FiO2) of more than or equal to 60% (his criteria will be adopted in the presence of permissive hypoxaemia and of congenital cardiopathy - cyanotic and non-cyanotic)
13. Not considered volume resuscitated by the attending intensivist
14. The blood pressure of the patient is not under control or the patient is not haemodynamically stable
15. Present an acute clinically significant active blood loss at the time of enrolment
16. Severe thrombocytopenia (platelet count less than 20.0 x 10^9/L or 20 000/mm^3)
17. Brain death or suspected brain death
18. Blood exchange-transfusion (manual or automated)
19. Plasmapheresis
20. Haemofiltration, if priming is done with blood
21. Extracorporeal membrane oxygenation (ECMO)
22. Decision taken to withhold or to withdraw critical care
23. Moribund and not expected to survive more than 24 hours (as judged by the attending intensivist)
24. Lack of commitment from the attending staff to continue active treatment of the patient
25. Expected to stay less than 24 hours in the Paediatric Intensive Care Unit (PICU) (as judged by the attending intensivist)
26. Refusal of consent by patient and/or parent
27. Refusal of consent by physician
28. Enrolment in another interventional study that could interfere with the TRIPICU trial
Anticipated start date 26/11/2001
Anticipated end date 28/08/2005
Status of trial Completed
Patient information material
Target number of participants 626
Interventions Giving more or less red blood cell transfusion.
Primary outcome measure(s) Number of patients who developed new or progressive multiple organ dysfunction syndrome.
Secondary outcome measure(s) 1. Descriptors of severity of cases of multiple organ dysfunction syndrome (Paediatric Logistic Organ Dysfunction [PELOD] score, maximal number of organ dysfunctions)
2. Mortality (28-day, ICU and hospital mortality rates)
3. Nosocomial infections
4. Length of mechanical ventilation
5. Length of ICU stay and of total hospital stay
6. Adverse events
7. Transfusion reactions
Sources of funding Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: 130770)
Trial website
Publications 1. 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17442904
2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/19789443
Contact name Dr  Jacques  Lacroix
  Address 3175 Cote Sainte-Catherine
  City/town Montréal
  Zip/Postcode H3T 1C5
  Country Canada
  Tel +1 514 7392589 or 3454931ext5556
  Fax +1 514 345 7731
  Email j_lacroix@videotron.ca
Sponsor Sainte-Justine Hospital - Research Centre (Canada)
  Address 3175 Côte Sainte-Catherine
  City/town Montréal, Québec
  Zip/Postcode H3T 1C5
  Country Canada
  Tel +1 514 345 4691
  Fax +1 514 345 4698
  Email centre@recherche-ste-justine.qc.ca
Date applied 27/06/2004
Last edited 15/11/2013
Date ISRCTN assigned 04/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.